SIMILAR PATTERNS OF AMINO ACIDS FOR 3OGP_B_017B200

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism		 Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1d2f MALY PROTEIN

(Escherichia
coli) 		PF00155
(Aminotran_1_2) 		5 ALA A 341
ILE A 343
GLY A 381
ILE A 383
LEU A 338
 None
 1.06A 3ogpA-1d2fA:
0.0		 3ogpA-1d2fA:
14.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1dlc DELTA-ENDOTOXIN
CRYIIIA

(Bacillus
thuringiensis) 		PF00555
(Endotoxin_M)
PF03944
(Endotoxin_C)
PF03945
(Endotoxin_N) 		5 LEU A 333
GLY A 623
ILE A 622
VAL A 526
LEU A 520
 None
 1.04A 3ogpA-1dlcA:
0.0		 3ogpA-1dlcA:
11.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1dxx DYSTROPHIN

(Homo sapiens) 		PF00307
(CH) 		5 LEU A  53
ALA A  80
GLY A  95
ILE A  94
LEU A  50
 None
 0.83A 3ogpA-1dxxA:
undetectable		 3ogpA-1dxxA:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ehk BA3-TYPE
CYTOCHROME-C OXIDASE

(Thermus
thermophilus) 		PF00115
(COX1) 		5 ALA A 534
ILE A 536
GLY A 528
ILE A 527
LEU A 274
 None
 0.91A 3ogpA-1ehkA:
undetectable		 3ogpA-1ehkA:
11.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1gz4 NAD-DEPENDENT MALIC
ENZYME

(Homo sapiens) 		PF00390
(malic)
PF03949
(Malic_M) 		5 ALA A 289
GLY A 282
SER A 523
VAL A 522
LEU A 498
 None
 1.03A 3ogpA-1gz4A:
0.0		 3ogpA-1gz4A:
13.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1gz5 ALPHA-TREHALOSE-PHOS
PHATE SYNTHASE

(Escherichia
coli) 		PF00982
(Glyco_transf_20) 		5 LEU A 382
ALA A 390
GLY A 226
ILE A 227
LEU A 394
 None
 1.05A 3ogpA-1gz5A:
undetectable		 3ogpA-1gz5A:
12.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1) 		PF00077
(RVP) 		5 LEU A  23
ASP A  25
ALA A  28
GLY A  48
VAL A  82
 A79  A 800 ( 3.8A)
A79  A 800 (-2.7A)
A79  A 800 (-3.1A)
A79  A 800 (-3.6A)
A79  A 800 (-4.5A)
 0.81A 3ogpA-1hvcA:
9.9		 3ogpA-1hvcA:
21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1) 		PF00077
(RVP) 		5 LEU A  23
ASP A  25
ALA A  28
GLY A  48
VAL A  82
 A79  A 800 ( 4.0A)
A79  A 800 (-2.8A)
A79  A 800 (-3.2A)
A79  A 800 (-4.1A)
A79  A 800 (-4.5A)
 0.93A 3ogpA-1hvcA:
9.9		 3ogpA-1hvcA:
21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1) 		PF00077
(RVP) 		5 LEU A  23
ASP A  25
ALA A  28
GLY A  49
ILE A  50
 A79  A 800 ( 3.8A)
A79  A 800 (-2.7A)
A79  A 800 (-3.1A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.8A)
 0.60A 3ogpA-1hvcA:
9.9		 3ogpA-1hvcA:
21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1) 		PF00077
(RVP) 		5 LEU A  23
ASP A  25
ALA A  28
GLY A  49
ILE A  50
 A79  A 800 ( 4.0A)
A79  A 800 (-2.8A)
A79  A 800 (-3.2A)
A79  A 800 (-3.4A)
A79  A 800 ( 4.0A)
 0.63A 3ogpA-1hvcA:
9.9		 3ogpA-1hvcA:
21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1) 		PF00077
(RVP) 		5 LEU A  23
ASP A  25
ALA A  28
ILE A  50
VAL A  82
 A79  A 800 ( 3.8A)
A79  A 800 (-2.7A)
A79  A 800 (-3.1A)
A79  A 800 (-3.8A)
A79  A 800 (-4.5A)
 0.65A 3ogpA-1hvcA:
9.9		 3ogpA-1hvcA:
21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1) 		PF00077
(RVP) 		5 LEU A  23
ASP A  25
ALA A  28
ILE A  50
VAL A  82
 A79  A 800 ( 4.0A)
A79  A 800 (-2.8A)
A79  A 800 (-3.2A)
A79  A 800 ( 4.0A)
A79  A 800 (-4.5A)
 0.69A 3ogpA-1hvcA:
9.9		 3ogpA-1hvcA:
21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1hyl HYPODERMA LINEATUM
COLLAGENASE

(Hypoderma
lineatum) 		PF00089
(Trypsin) 		5 LEU A 209
ALA A 136
ILE A 134
GLY A 183
VAL A 231
 None
 1.02A 3ogpA-1hylA:
1.3		 3ogpA-1hylA:
19.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ipi HOLLIDAY JUNCTION
RESOLVASE

(Pyrococcus
furiosus) 		PF01870
(Hjc) 		5 LEU A  12
ALA A  36
GLY A  74
ILE A  75
VAL A  47
 None
 0.93A 3ogpA-1ipiA:
0.0		 3ogpA-1ipiA:
23.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ixp PYRIDOXINE
5'-PHOSPHATE
SYNTHASE

(Escherichia
coli) 		PF03740
(PdxJ) 		6 LEU A 239
ALA A 204
ILE A 206
GLY A 192
ILE A 214
LEU A   4
 None
None
None
None
PO4  A1002 (-4.4A)
None
 1.25A 3ogpA-1ixpA:
0.0		 3ogpA-1ixpA:
19.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1kut PHOSPHORIBOSYLAMINOI
MIDAZOLE-SUCCINOCARB
OXAMIDE SYNTHASE

(Thermotoga
maritima) 		PF01259
(SAICAR_synt) 		5 LEU A  19
ALA A  44
ILE A 187
VAL A  74
LEU A  72
 None
 1.00A 3ogpA-1kutA:
undetectable		 3ogpA-1kutA:
18.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1lam LEUCINE
AMINOPEPTIDASE

(Bos taurus) 		PF00883
(Peptidase_M17)
PF02789
(Peptidase_M17_N) 		5 LEU A 436
ALA A 342
GLY A 298
ILE A 280
LEU A 343
 None
 1.06A 3ogpA-1lamA:
undetectable		 3ogpA-1lamA:
11.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1lsh LIPOVITELLIN (LV-1N,
LV-1C)

(Ichthyomyzon
unicuspis) 		PF01347
(Vitellogenin_N)
PF09172
(DUF1943) 		5 ALA A 123
GLY A 814
ILE A 815
VAL A  69
LEU A  97
 None
None
UPL  A2014 ( 4.6A)
None
None
 0.99A 3ogpA-1lshA:
undetectable		 3ogpA-1lshA:
7.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ot5 KEXIN

(Saccharomyces
cerevisiae) 		PF00082
(Peptidase_S8)
PF01483
(P_proprotein) 		5 ILE A 532
GLY A 564
ILE A 492
VAL A 510
LEU A 526
 None
 1.00A 3ogpA-1ot5A:
undetectable		 3ogpA-1ot5A:
14.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1py5 TGF-BETA RECEPTOR
TYPE I

(Homo sapiens) 		PF00069
(Pkinase)
PF08515
(TGF_beta_GS) 		5 LEU A 495
ALA A 306
MET A 404
GLY A 405
LEU A 492
 None
 1.01A 3ogpA-1py5A:
undetectable		 3ogpA-1py5A:
17.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus) 		PF00077
(RVP) 		5 LEU A  23
ASP A  25
ALA A  28
GLY A  49
ILE A  50
 None
 0.53A 3ogpA-1sivA:
15.7		 3ogpA-1sivA:
28.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1txg GLYCEROL-3-PHOSPHATE
DEHYDROGENASE
[NAD(P)+]

(Archaeoglobus
fulgidus) 		PF01210
(NAD_Gly3P_dh_N)
PF07479
(NAD_Gly3P_dh_C) 		5 ALA A 190
GLY A 184
ILE A 232
VAL A 114
LEU A 107
 None
 1.01A 3ogpA-1txgA:
undetectable		 3ogpA-1txgA:
14.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1umf CHORISMATE SYNTHASE

(Helicobacter
pylori) 		PF01264
(Chorismate_synt) 		6 LEU A   4
ALA A 135
ILE A  79
GLY A  22
ILE A  21
LEU A  10
 None
 1.50A 3ogpA-1umfA:
undetectable		 3ogpA-1umfA:
16.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2aka DYNAMIN-1

(Rattus
norvegicus) 		PF00350
(Dynamin_N)
PF01031
(Dynamin_M) 		5 LEU B 181
ALA B 186
ILE B 189
ILE B 201
LEU B 187
 None
 0.97A 3ogpA-2akaB:
undetectable		 3ogpA-2akaB:
15.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bku IMPORTIN BETA-1
SUBUNIT

(Saccharomyces
cerevisiae) 		PF03810
(IBN_N)
PF13513
(HEAT_EZ) 		6 LEU B 645
ALA B 659
ILE B 657
ILE B 666
VAL B 684
LEU B 648
 None
 1.40A 3ogpA-2bkuB:
undetectable		 3ogpA-2bkuB:
8.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2c7i PUTATIVE LIPOATE
PROTEIN LIGASE

(Thermoplasma
acidophilum) 		PF03099
(BPL_LplA_LipB) 		5 LEU A 119
ALA A 213
ILE A 207
VAL A 203
LEU A 117
 None
 1.01A 3ogpA-2c7iA:
undetectable		 3ogpA-2c7iA:
19.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2cf5 CINNAMYL ALCOHOL
DEHYDROGENASE

(Arabidopsis
thaliana) 		PF00107
(ADH_zinc_N)
PF08240
(ADH_N) 		6 LEU A 262
ILE A 249
MET A 274
GLY A 275
ILE A 277
LEU A 271
 None
 1.41A 3ogpA-2cf5A:
undetectable		 3ogpA-2cf5A:
16.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2cg8 DIHYDRONEOPTERIN
ALDOLASE
6-HYDROXYMETHYL-7,8-
DIHYDROPTERIN
SYNTHASE

(Streptococcus
pneumoniae) 		PF01288
(HPPK)
PF02152
(FolB) 		5 LEU A  79
ALA A  32
ILE A  33
ILE A  29
LEU A  95
 None
 0.94A 3ogpA-2cg8A:
undetectable		 3ogpA-2cg8A:
16.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2fa0 HMG-COA SYNTHASE

(Brassica juncea) 		PF01154
(HMG_CoA_synt_N)
PF08540
(HMG_CoA_synt_C) 		5 LEU A  65
ALA A 166
ILE A  12
ILE A 169
LEU A  64
 None
 0.92A 3ogpA-2fa0A:
undetectable		 3ogpA-2fa0A:
15.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE

(Equine
infectious
anemia virus) 		PF00077
(RVP) 		5 LEU A  23
ASP A  25
ALA A  28
GLY A  54
VAL A  87
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 ( 4.9A)
 0.62A 3ogpA-2fmbA:
15.4		 3ogpA-2fmbA:
33.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE

(Equine
infectious
anemia virus) 		PF00077
(RVP) 		5 LEU A  23
ASP A  25
ALA A  28
GLY A  55
VAL A  87
 None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.4A)
LP1  A 201 ( 4.9A)
 0.64A 3ogpA-2fmbA:
15.4		 3ogpA-2fmbA:
33.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2gzx PUTATIVE TATD
RELATED DNASE

(Staphylococcus
aureus) 		PF01026
(TatD_DNase) 		6 ALA A 118
ILE A 115
MET A  93
GLY A  91
ILE A  60
LEU A 117
 None
 1.42A 3ogpA-2gzxA:
undetectable		 3ogpA-2gzxA:
17.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2iya OLEANDOMYCIN
GLYCOSYLTRANSFERASE

(Streptomyces
antibioticus) 		PF00201
(UDPGT) 		5 ALA A 413
GLY A 418
ILE A 419
VAL A  43
LEU A  36
 None
 0.83A 3ogpA-2iyaA:
undetectable		 3ogpA-2iyaA:
13.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ld4 ANAMORSIN

(Homo sapiens) 		PF08241
(Methyltransf_11) 		5 LEU A 119
ALA A  84
ILE A  62
VAL A 127
LEU A 124
 None
 0.91A 3ogpA-2ld4A:
undetectable		 3ogpA-2ld4A:
22.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2pkg SERINE/THREONINE-PRO
TEIN PHOSPHATASE 2A
65 KDA REGULATORY
SUBUNIT A ALPHA
ISOFORM

(Homo sapiens) 		PF02985
(HEAT)
PF13646
(HEAT_2) 		5 LEU A 567
ALA A 582
GLY A 548
ILE A 547
LEU A 564
 None
 1.02A 3ogpA-2pkgA:
undetectable		 3ogpA-2pkgA:
13.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2q1z ANTI-SIGMA FACTOR
CHRR,
TRANSCRIPTIONAL
ACTIVATOR CHRR

(Rhodobacter
sphaeroides) 		PF12973
(Cupin_7)
PF13490
(zf-HC2) 		5 ALA B 192
GLY B 145
SER B   8
VAL B   7
LEU B 148
 None
 1.01A 3ogpA-2q1zB:
undetectable		 3ogpA-2q1zB:
17.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1) 		PF00077
(RVP) 		5 LEU A  23
ASP A  25
ALA A  28
GLY A  49
ILE A  50
 None
AB1  A 501 (-2.4A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
 0.65A 3ogpA-2rkfA:
15.1		 3ogpA-2rkfA:
27.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3c5w PP2A A SUBUNIT

(Homo sapiens) 		PF02985
(HEAT)
PF13646
(HEAT_2) 		5 LEU A 567
ALA A 582
GLY A 548
ILE A 547
LEU A 564
 None
 0.89A 3ogpA-3c5wA:
undetectable		 3ogpA-3c5wA:
18.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3eqn GLUCAN
1,3-BETA-GLUCOSIDASE

(Phanerochaete
chrysosporium) 		PF12708
(Pectate_lyase_3) 		5 ASP A 552
ALA A 551
ILE A 613
SER A 609
VAL A 571
 None
 0.93A 3ogpA-3eqnA:
undetectable		 3ogpA-3eqnA:
10.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3g79 NDP-N-ACETYL-D-GALAC
TOSAMINURONIC ACID
DEHYDROGENASE

(Methanosarcina
mazei) 		PF00984
(UDPG_MGDP_dh)
PF03720
(UDPG_MGDP_dh_C)
PF03721
(UDPG_MGDP_dh_N) 		5 LEU A  11
GLY A 201
ILE A 202
SER A   6
LEU A  12
 None
 1.03A 3ogpA-3g79A:
undetectable		 3ogpA-3g79A:
14.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ghp CELLULOSOMAL
SCAFFOLDIN ADAPTOR
PROTEIN B

(Acetivibrio
cellulolyticus) 		PF00963
(Cohesin) 		5 LEU A 120
MET A 143
GLY A 146
ILE A 147
VAL A  31
 None
 1.07A 3ogpA-3ghpA:
undetectable		 3ogpA-3ghpA:
18.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gr8 NADPH DEHYDROGENASE

(Geobacillus
kaustophilus) 		PF00724
(Oxidored_FMN) 		5 LEU A  88
ALA A 156
GLY A 149
VAL A  37
LEU A  85
 None
 1.01A 3ogpA-3gr8A:
undetectable		 3ogpA-3gr8A:
15.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3l91 ACYL-HOMOSERINE
LACTONE ACYLASE PVDQ
SUBUNIT BETA

(Pseudomonas
aeruginosa) 		PF01804
(Penicil_amidase) 		6 ALA B 469
GLY B 399
ILE B 400
SER B 289
VAL B 504
LEU B 472
 None
 1.38A 3ogpA-3l91B:
undetectable		 3ogpA-3l91B:
11.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3m4r UNCHARACTERIZED
PROTEIN

(Thermoplasma
acidophilum) 		PF00596
(Aldolase_II) 		5 LEU A 188
ILE A 202
GLY A  25
SER A  39
VAL A 125
 None
 1.02A 3ogpA-3m4rA:
undetectable		 3ogpA-3m4rA:
19.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1) 		PF00077
(RVP) 		5 LEU A  23
ASP A  25
ALA A  28
GLY A  48
VAL A  82
 None
 0.90A 3ogpA-3mwsA:
15.8		 3ogpA-3mwsA:
28.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1) 		PF00077
(RVP) 		5 LEU A  23
ASP A  25
ALA A  28
GLY A  49
ILE A  50
 None
 0.57A 3ogpA-3mwsA:
15.8		 3ogpA-3mwsA:
28.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1) 		PF00077
(RVP) 		5 LEU A  23
ASP A  25
ALA A  28
ILE A  50
VAL A  82
 None
 0.81A 3ogpA-3mwsA:
15.8		 3ogpA-3mwsA:
28.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mzk PROTEIN TRANSPORT
PROTEIN SEC16

(Saccharomyces
cerevisiae) 		PF12931
(Sec16_C)
PF12932
(Sec16) 		5 LEU B1378
GLY B1354
SER B1364
VAL B1365
LEU B1382
 None
 0.81A 3ogpA-3mzkB:
undetectable		 3ogpA-3mzkB:
14.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3r9w GTPASE ERA

(Aquifex
aeolicus) 		PF01926
(MMR_HSR1)
PF07650
(KH_2) 		5 ASP A 187
GLY A 298
SER A  29
VAL A  28
LEU A 188
 None
None
MG  A 401 ( 4.8A)
None
None
 1.02A 3ogpA-3r9wA:
undetectable		 3ogpA-3r9wA:
18.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3slz GAG-PRO-POL
POLYPROTEIN

(Murine leukemia
virus) 		PF00077
(RVP) 		5 LEU A  30
ASP A  32
ALA A  35
GLY A  56
LEU A  92
 None
3TL  A 126 (-2.4A)
3TL  A 126 ( 4.0A)
3TL  A 126 (-3.4A)
3TL  A 126 (-4.6A)
 0.47A 3ogpA-3slzA:
12.0		 3ogpA-3slzA:
26.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1) 		PF00077
(RVP) 		5 LEU A  23
ASP A  25
ALA A  28
GLY A  49
ILE A  50
 SO4  A 101 (-4.2A)
017  A 201 (-2.6A)
017  A 201 (-3.5A)
017  A 201 (-4.0A)
017  A 201 (-3.3A)
 0.52A 3ogpA-3t3cA:
15.1		 3ogpA-3t3cA:
29.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1) 		PF00077
(RVP) 		5 LEU A  23
ASP A  25
ALA A  28
GLY A  49
ILE A  50
 None
017  A 201 (-2.6A)
017  A 201 (-3.4A)
017  A 201 (-3.0A)
017  A 201 (-3.3A)
 0.51A 3ogpA-3ttpA:
15.4		 3ogpA-3ttpA:
26.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1) 		PF00077
(RVP) 		5 LEU A  23
ASP A  25
ALA A  28
GLY A  49
ILE A  50
 None
017  A 202 ( 2.5A)
017  A 201 (-3.4A)
017  A 202 (-2.9A)
017  A 201 ( 3.5A)
 0.42A 3ogpA-3u7sA:
15.5		 3ogpA-3u7sA:
28.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4akr F-ACTIN-CAPPING
PROTEIN SUBUNIT
ALPHA
F-ACTIN-CAPPING
PROTEIN SUBUNIT BETA

(Dictyostelium
discoideum) 		PF01115
(F_actin_cap_B)
PF01267
(F-actin_cap_A) 		5 ILE B  21
GLY B  27
ILE A  10
VAL A  26
LEU B  16
 None
 0.94A 3ogpA-4akrB:
undetectable		 3ogpA-4akrB:
18.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4b2g GH3-1 AUXIN
CONJUGATING ENZYME

(Vitis vinifera) 		PF03321
(GH3) 		5 LEU A 152
GLY A 295
ILE A 296
VAL A 223
LEU A 226
 None
 1.00A 3ogpA-4b2gA:
undetectable		 3ogpA-4b2gA:
13.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4bub UDP-N-ACETYLMURAMOYL
-L-ALANYL-D-GLUTAMAT
E--LD-LYSINE LIGASE

(Thermotoga
maritima) 		PF01225
(Mur_ligase)
PF02875
(Mur_ligase_C)
PF08245
(Mur_ligase_M) 		5 LEU A 356
ALA A 346
GLY A 454
VAL A 359
LEU A 355
 None
 0.84A 3ogpA-4bubA:
undetectable		 3ogpA-4bubA:
12.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4c7p RALF

(Legionella
pneumophila) 		PF01369
(Sec7) 		5 LEU A 264
ALA A 308
ILE A 305
GLY A 202
ILE A 295
 None
 1.05A 3ogpA-4c7pA:
undetectable		 3ogpA-4c7pA:
15.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4dwl BBP7

(Bordetella
virus BPP1) 		no annotation 5 ALA A  71
GLY A 110
ILE A 112
VAL A 120
LEU A  68
 None
 1.00A 3ogpA-4dwlA:
undetectable		 3ogpA-4dwlA:
18.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fdd TRANSPORTIN-1

(Homo sapiens) 		PF03810
(IBN_N)
PF13513
(HEAT_EZ) 		5 ILE A 735
MET A 710
GLY A 714
VAL A 786
LEU A 778
 None
 0.94A 3ogpA-4fddA:
undetectable		 3ogpA-4fddA:
8.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4iyo CYSTATHIONINE
GAMMA-LYASE-LIKE
PROTEIN, LYS201A
MODIFIED

(Xanthomonas
oryzae) 		PF01053
(Cys_Met_Meta_PP) 		5 LEU B 212
ALA B  21
ILE B  22
GLY B  25
LEU B 258
 None
 1.03A 3ogpA-4iyoB:
undetectable		 3ogpA-4iyoB:
12.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4kf7 NUP188

(Thermothelomyces
thermophila) 		PF10487
(Nup188) 		5 ALA A1066
ILE A1076
SER A1105
VAL A1104
LEU A 133
 None
 0.94A 3ogpA-4kf7A:
undetectable		 3ogpA-4kf7A:
6.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4l9r INOSITOL
2-DEHYDROGENASE/D-CH
IRO-INOSITOL
3-DEHYDROGENASE

(Bacillus
subtilis) 		PF01408
(GFO_IDH_MocA)
PF02894
(GFO_IDH_MocA_C) 		5 LEU A 184
ALA A 139
GLY A 246
ILE A 247
LEU A 140
 None
 1.04A 3ogpA-4l9rA:
undetectable		 3ogpA-4l9rA:
17.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4lac PP2A SCAFFOLD
SUBUNIT A,
TRUNCATED, AN
INTERNAL DELETION OF
PP2A A

(Homo sapiens) 		PF02985
(HEAT)
PF13646
(HEAT_2) 		5 LEU A 567
ALA A 582
GLY A 548
ILE A 547
LEU A 564
 None
 0.85A 3ogpA-4lacA:
undetectable		 3ogpA-4lacA:
18.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4lhu 9C2 TCR GAMMA CHAIN

(Homo sapiens) 		PF07654
(C1-set)
PF07686
(V-set) 		5 LEU G  62
ASP G  60
ILE G  36
ILE G  84
LEU G  51
 None
 0.97A 3ogpA-4lhuG:
undetectable		 3ogpA-4lhuG:
17.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4mf9 HEMIN DEGRADING
FACTOR

(Pseudomonas
aeruginosa) 		PF05171
(HemS) 		5 LEU A  56
ALA A  66
ILE A  73
VAL A 121
LEU A  63
 None
 1.00A 3ogpA-4mf9A:
undetectable		 3ogpA-4mf9A:
13.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4n03 ABC-TYPE
BRANCHED-CHAIN AMINO
ACID TRANSPORT
SYSTEMS PERIPLASMIC
COMPONENT-LIKE
PROTEIN

(Thermomonospora
curvata) 		PF13458
(Peripla_BP_6) 		5 LEU A 119
ILE A  56
GLY A 335
ILE A 338
LEU A  54
 None
 0.90A 3ogpA-4n03A:
undetectable		 3ogpA-4n03A:
13.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ndm T-CELL GAMMA
PROTEIN,T-CELL
RECEPTOR BETA-2
CHAIN C REGION

(Homo sapiens) 		PF07654
(C1-set)
PF07686
(V-set) 		5 LEU A  60
ASP A  58
ILE A  34
ILE A  82
LEU A  49
 None
 0.90A 3ogpA-4ndmA:
undetectable		 3ogpA-4ndmA:
16.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1) 		PF00077
(RVP) 		5 LEU A  23
ASP A  25
ALA A  28
GLY A  49
ILE A  50
 None
RIT  A 500 (-2.4A)
RIT  A 500 (-3.6A)
RIT  A 500 (-3.4A)
RIT  A 500 (-4.3A)
 0.56A 3ogpA-4njvA:
15.1		 3ogpA-4njvA:
32.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4p6v NA(+)-TRANSLOCATING
NADH-QUINONE
REDUCTASE SUBUNIT E

(Vibrio cholerae) 		PF02508
(Rnf-Nqr) 		5 LEU E 109
ALA E  44
ILE E 122
VAL E  31
LEU E  41
 None
 1.04A 3ogpA-4p6vE:
undetectable		 3ogpA-4p6vE:
20.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4pz2 ZMALDH

(Zea mays) 		PF00171
(Aldedh) 		5 ALA A 195
GLY A 100
ILE A 102
VAL A 110
LEU A 144
 None
 0.98A 3ogpA-4pz2A:
undetectable		 3ogpA-4pz2A:
12.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4s0v HUMAN OREXIN
RECEPTOR TYPE 2
FUSION PROTEIN TO P.
ABYSII GLYCOGEN
SYNTHASE

(Homo sapiens;
Pyrococcus
abyssi) 		PF00001
(7tm_1)
PF00534
(Glycos_transf_1) 		5 ALA A1128
GLY A1155
ILE A1156
VAL A1143
LEU A1146
 None
 1.04A 3ogpA-4s0vA:
undetectable		 3ogpA-4s0vA:
14.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4txv CYTOCHROME C OXIDASE
SUBUNIT 2
THIOL:DISULFIDE
INTERCHANGE PROTEIN
TLPA

(Bradyrhizobium
diazoefficiens) 		PF00116
(COX2)
PF08534
(Redoxin) 		5 ALA B 200
ILE A 195
GLY B 227
ILE B 242
VAL B 246
 None
 1.07A 3ogpA-4txvB:
undetectable		 3ogpA-4txvB:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xuk PUTATIVE HYDROLASE

(Acinetobacter
sp. NBRC 100985) 		PF00753
(Lactamase_B) 		5 ALA A 107
ILE A 105
GLY A 317
ILE A 318
LEU A  66
 None
 1.06A 3ogpA-4xukA:
undetectable		 3ogpA-4xukA:
15.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4z79 LEIOMODIN-1
ACTIN-BINDING SITE 2
(ABS2)

(Homo sapiens) 		no annotation 6 LEU A 417
ALA A 410
ILE A 381
GLY A 403
ILE A 404
LEU A 383
 None
None
GOL  A 502 ( 4.3A)
None
None
None
 1.35A 3ogpA-4z79A:
undetectable		 3ogpA-4z79A:
20.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4z8g TROPOMODULIN-1,
LEIOMODIN-1 CHIMERA
(TP1 ABS2)

(Homo sapiens) 		no annotation 6 LEU A 417
ALA A 410
ILE A 381
GLY A 403
ILE A 404
LEU A 383
 None
 1.34A 3ogpA-4z8gA:
undetectable		 3ogpA-4z8gA:
23.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4z9r OMEGA-3
POLYUNSATURATED
FATTY ACID SYNTHASE
SUBUNIT PFAD

(Shewanella
oneidensis) 		PF03060
(NMO) 		5 LEU A 353
ILE A 337
GLY A 275
SER A 468
LEU A 354
 None
None
FMN  A 602 ( 4.3A)
None
None
 0.88A 3ogpA-4z9rA:
undetectable		 3ogpA-4z9rA:
10.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4zj8 HUMAN OX1R FUSION
PROTEIN TO P.ABYSII
GLYCOGEN SYNTHASE

(Homo sapiens;
Pyrococcus
abyssi) 		PF00001
(7tm_1)
PF00534
(Glycos_transf_1) 		5 ALA A1128
GLY A1155
ILE A1156
VAL A1143
LEU A1146
 None
 1.04A 3ogpA-4zj8A:
undetectable		 3ogpA-4zj8A:
13.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5bnn CAPSID PROTEIN VP1

(Enterovirus D) 		PF00073
(Rhv) 		5 LEU A 113
ILE A 189
GLY A 218
ILE A  95
VAL A 195
 None
 1.04A 3ogpA-5bnnA:
undetectable		 3ogpA-5bnnA:
16.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5csl ACETYL-COA
CARBOXYLASE

(Saccharomyces
cerevisiae) 		PF00289
(Biotin_carb_N)
PF00364
(Biotin_lipoyl)
PF01039
(Carboxyl_trans)
PF02785
(Biotin_carb_C)
PF02786
(CPSase_L_D2)
PF08326
(ACC_central) 		5 LEU A 475
ILE A 509
SER A 491
VAL A 492
LEU A 478
 None
 0.93A 3ogpA-5cslA:
undetectable		 3ogpA-5cslA:
4.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5cvo WD REPEAT-CONTAINING
PROTEIN 48

(Homo sapiens) 		PF00400
(WD40) 		5 LEU A 226
ALA A 215
GLY A 254
VAL A 267
LEU A 258
 None
 1.03A 3ogpA-5cvoA:
undetectable		 3ogpA-5cvoA:
9.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5e7p CELL DIVISION
CONTROL PROTEIN
CDC48

(Mycolicibacterium
smegmatis) 		PF00004
(AAA)
PF02359
(CDC48_N) 		5 LEU A 614
ALA A 591
MET A 556
GLY A 552
LEU A 610
 None
 1.01A 3ogpA-5e7pA:
undetectable		 3ogpA-5e7pA:
8.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5fms INTRAFLAGELLAR
TRANSPORT PROTEIN 52
HOMOLOG

(Mus musculus) 		PF09822
(ABC_transp_aux) 		5 ALA A 212
MET A  86
GLY A 215
ILE A 197
VAL A 236
 None
 1.05A 3ogpA-5fmsA:
undetectable		 3ogpA-5fmsA:
21.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5gkm AT5G51070/K3K7_27

(Arabidopsis
thaliana) 		PF02861
(Clp_N) 		5 LEU A 212
ALA A 138
ILE A 132
SER A 128
LEU A 215
 None
 0.79A 3ogpA-5gkmA:
undetectable		 3ogpA-5gkmA:
19.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ie2 OXALATE--COA LIGASE

(Arabidopsis
thaliana) 		PF00501
(AMP-binding)
PF13193
(AMP-binding_C) 		5 LEU A  10
ALA A 188
ILE A 194
VAL A  13
LEU A   9
 None
 0.99A 3ogpA-5ie2A:
undetectable		 3ogpA-5ie2A:
12.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5im3 RIBONUCLEOSIDE-DIPHO
SPHATE REDUCTASE

(Pseudomonas
aeruginosa) 		PF00317
(Ribonuc_red_lgN)
PF02867
(Ribonuc_red_lgC)
PF03477
(ATP-cone) 		5 LEU A 876
ALA A 873
ILE A 590
GLY A 661
ILE A 662
 None
 1.01A 3ogpA-5im3A:
undetectable		 3ogpA-5im3A:
7.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5izd D-GLYCERALDEHYDE
DEHYDROGENASE
(NADP(+))

(Thermoplasma
acidophilum) 		PF00171
(Aldedh) 		5 ALA A 162
GLY A 140
ILE A 141
VAL A 193
LEU A 163
 None
 1.01A 3ogpA-5izdA:
undetectable		 3ogpA-5izdA:
13.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5j84 DIHYDROXY-ACID
DEHYDRATASE

(Rhizobium
leguminosarum) 		PF00920
(ILVD_EDD) 		5 LEU A 333
ALA A 272
GLY A 303
ILE A 267
LEU A 336
 None
 0.88A 3ogpA-5j84A:
undetectable		 3ogpA-5j84A:
11.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5k1c WD REPEAT-CONTAINING
PROTEIN 48

(Homo sapiens) 		PF00400
(WD40) 		5 LEU B 226
ALA B 215
GLY B 254
VAL B 267
LEU B 258
 None
 1.00A 3ogpA-5k1cB:
undetectable		 3ogpA-5k1cB:
11.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5kqi CATALASE-PEROXIDASE

(Burkholderia
pseudomallei) 		PF00141
(peroxidase) 		5 LEU A 634
ALA A 621
GLY A 493
VAL A 735
LEU A 626
 None
 0.88A 3ogpA-5kqiA:
undetectable		 3ogpA-5kqiA:
10.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5mqp GLYCOSIDE HYDROLASE
BT_1002

(Bacteroides
thetaiotaomicron) 		no annotation 5 LEU A  43
ALA A  50
GLY A  88
VAL A  80
LEU A  47
 None
 0.92A 3ogpA-5mqpA:
undetectable		 3ogpA-5mqpA:
11.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5nux CHROMATE REDUCTASE

(Thermus
scotoductus) 		no annotation 5 LEU A  86
ALA A 164
GLY A 157
VAL A  35
LEU A  83
 None
 1.00A 3ogpA-5nuxA:
undetectable		 3ogpA-5nuxA:
19.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t2z PROTEASE

(Human
immunodeficiency
virus 1) 		PF00077
(RVP) 		5 LEU A  23
ASP A  25
ALA A  28
GLY A  49
ILE A  50
 None
 0.50A 3ogpA-5t2zA:
15.3		 3ogpA-5t2zA:
31.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ubk ACYL-HOMOSERINE
LACTONE ACYLASE PVDQ

(Pseudomonas
aeruginosa) 		PF01804
(Penicil_amidase) 		6 ALA A 253
GLY A 183
ILE A 184
SER A  73
VAL A 288
LEU A 256
 None
 1.34A 3ogpA-5ubkA:
undetectable		 3ogpA-5ubkA:
9.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5um6 UBIQUITIN-ACTIVATING
ENZYME E1 1

(Schizosaccharomyces
pombe) 		PF00899
(ThiF)
PF09358
(E1_UFD)
PF10585
(UBA_e1_thiolCys)
PF16190
(E1_FCCH)
PF16191
(E1_4HB) 		5 LEU A 443
ILE A 425
GLY A 457
SER A 496
VAL A 495
 None
 1.02A 3ogpA-5um6A:
undetectable		 3ogpA-5um6A:
8.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5wva SHORT-CHAIN
DEHYDROGENASE

(Serratia
marcescens) 		no annotation 5 ALA A  66
ILE A  64
GLY A  16
VAL A 124
LEU A  74
 None
 0.98A 3ogpA-5wvaA:
undetectable		 3ogpA-5wvaA:
12.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5wwo ESSENTIAL NUCLEAR
PROTEIN 1

(Saccharomyces
cerevisiae) 		PF05291
(Bystin) 		5 ALA A 213
ILE A 211
GLY A 218
ILE A 220
VAL A 235
 None
 1.07A 3ogpA-5wwoA:
undetectable		 3ogpA-5wwoA:
14.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6cjb CYSTATHIONINE
BETA-LYASE

(Legionella
pneumophila) 		no annotation 5 LEU A 201
ALA A  10
ILE A  11
GLY A  14
LEU A 247
 None
 1.05A 3ogpA-6cjbA:
undetectable		 3ogpA-6cjbA:
20.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6en4 SPLICING FACTOR 3B
SUBUNIT 1

(Homo sapiens) 		no annotation 5 ILE C1036
GLY C 991
ILE C 993
VAL C1001
LEU C1038
 None
 1.04A 3ogpA-6en4C:
undetectable		 3ogpA-6en4C:
20.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6fiv RETROPEPSIN

(Feline
immunodeficiency
virus) 		PF00077
(RVP) 		8 LEU A  28
ASP A  30
ALA A  33
ILE A  35
MET A  56
GLY A  58
VAL A  99
LEU A 101
 None
3TL  A 201 (-3.5A)
3TL  A 201 (-4.0A)
3TL  A 201 ( 4.3A)
3TL  A 201 (-4.7A)
3TL  A 201 (-3.4A)
None
3TL  A 201 (-4.8A)
 0.64A 3ogpA-6fivA:
21.7		 3ogpA-6fivA:
95.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2) 		PF00077
(RVP) 		5 LEU A  23
ASP A  25
ALA A  28
GLY A  49
ILE A  50
 None
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.94A 3ogpA-6upjA:
15.5		 3ogpA-6upjA:
29.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ecg GLUTAMINE
PHOSPHORIBOSYLPYROPH
OSPHATE
AMIDOTRANSFERASE

(Escherichia
coli) 		PF00156
(Pribosyltran)
PF13522
(GATase_6) 		5 GLY A 430
ALA A 431
ASP A 432
ILE A 378
LEU A 434
 None
 1.03A 3ogpB-1ecgA:
undetectable		 3ogpB-1ecgA:
13.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ehk BA3-TYPE
CYTOCHROME-C OXIDASE

(Thermus
thermophilus) 		PF00115
(COX1) 		5 ALA A 534
ILE A 536
GLY A 528
ILE A 527
LEU A 274
 None
 1.02A 3ogpB-1ehkA:
undetectable		 3ogpB-1ehkA:
11.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1) 		PF00077
(RVP) 		6 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 A79  A 800 (-2.7A)
A79  A 800 (-3.0A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.8A)
 0.43A 3ogpB-1hvcA:
10.0		 3ogpB-1hvcA:
21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1) 		PF00077
(RVP) 		6 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 A79  A 800 (-2.8A)
A79  A 800 (-3.0A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 (-3.4A)
A79  A 800 ( 4.0A)
 0.43A 3ogpB-1hvcA:
10.0		 3ogpB-1hvcA:
21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1inp INOSITOL
POLYPHOSPHATE
1-PHOSPHATASE

(Bos taurus) 		PF00459
(Inositol_P) 		5 GLY A 227
ILE A 143
MET A 198
GLY A 222
ILE A 230
 None
 1.00A 3ogpB-1inpA:
undetectable		 3ogpB-1inpA:
15.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1j0a 1-AMINOCYCLOPROPANE-
1-CARBOXYLATE
DEAMINASE

(Pyrococcus
horikoshii) 		PF00291
(PALP) 		5 GLY A  88
ALA A  90
GLY A  49
ILE A  50
LEU A  58
 None
 0.97A 3ogpB-1j0aA:
undetectable		 3ogpB-1j0aA:
17.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1jx2 MYOSIN-2 HEAVY
CHAIN,DYNAMIN-A

(Dictyostelium
discoideum) 		PF00063
(Myosin_head)
PF02736
(Myosin_N) 		5 GLY A 298
ALA A 299
MET A 353
ILE A 291
LEU A 309
 None
 0.93A 3ogpB-1jx2A:
undetectable		 3ogpB-1jx2A:
7.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1qho ALPHA-AMYLASE

(Geobacillus
stearothermophilus) 		PF00128
(Alpha-amylase)
PF00686
(CBM_20)
PF01833
(TIG)
PF02806
(Alpha-amylase_C) 		5 GLY A 221
ALA A 222
ASP A 223
ILE A 125
LEU A 217
 None
 1.02A 3ogpB-1qhoA:
undetectable		 3ogpB-1qhoA:
11.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus) 		PF00077
(RVP) 		5 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
 None
 0.80A 3ogpB-1sivA:
15.9		 3ogpB-1sivA:
28.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus) 		PF00077
(RVP) 		6 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 0.39A 3ogpB-1sivA:
15.9		 3ogpB-1sivA:
28.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ve1 O-ACETYLSERINE
SULFHYDRYLASE

(Thermus
thermophilus) 		PF00291
(PALP) 		5 GLY A 108
ILE A  89
GLY A  74
ILE A  75
LEU A 111
 None
 0.93A 3ogpB-1ve1A:
undetectable		 3ogpB-1ve1A:
19.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1x7f OUTER SURFACE
PROTEIN

(Bacillus cereus) 		PF05913
(DUF871) 		5 GLY A  92
ALA A  93
ASP A  94
ILE A  55
LEU A  68
 None
 0.92A 3ogpB-1x7fA:
undetectable		 3ogpB-1x7fA:
14.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bwg GMP REDUCTASE I

(Homo sapiens) 		PF00478
(IMPDH) 		5 GLY A 172
ALA A 173
ASP A 174
ILE A 175
LEU A 168
 None
 0.95A 3ogpB-2bwgA:
undetectable		 3ogpB-2bwgA:
14.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bzn GMP REDUCTASE 2

(Homo sapiens) 		PF00478
(IMPDH) 		5 GLY A 172
ALA A 173
ASP A 174
ILE A 175
LEU A 168
 None
 0.98A 3ogpB-2bznA:
undetectable		 3ogpB-2bznA:
15.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2f9z CHEMOTAXIS PROTEIN
CHEC

(Thermotoga
maritima) 		PF04509
(CheC) 		5 ALA A  23
ILE A  26
MET A 117
GLY A  18
ILE A  17
 None
 1.01A 3ogpB-2f9zA:
undetectable		 3ogpB-2f9zA:
22.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE

(Equine
infectious
anemia virus) 		PF00077
(RVP) 		5 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  54
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
 0.83A 3ogpB-2fmbA:
15.6		 3ogpB-2fmbA:
33.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE

(Equine
infectious
anemia virus) 		PF00077
(RVP) 		5 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
 LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
 0.17A 3ogpB-2fmbA:
15.6		 3ogpB-2fmbA:
33.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2gwc GLUTAMATE CYSTEINE
LIGASE

(Brassica juncea) 		PF04107
(GCS2) 		5 GLY A 388
ALA A 389
ASP A 390
ILE A 270
LEU A 400
 None
 0.88A 3ogpB-2gwcA:
undetectable		 3ogpB-2gwcA:
14.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2jgr YEGS

(Escherichia
coli) 		PF00781
(DAGK_cat) 		5 ASP A 218
GLY A 219
ILE A 124
GLY A 199
LEU A 215
 None
 1.01A 3ogpB-2jgrA:
undetectable		 3ogpB-2jgrA:
17.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2oqr SENSORY TRANSDUCTION
PROTEIN REGX3

(Mycobacterium
tuberculosis) 		PF00072
(Response_reg)
PF00486
(Trans_reg_C) 		5 GLY A  45
ALA A  46
ASP A  47
ILE A  48
LEU A   5
 None
 0.89A 3ogpB-2oqrA:
undetectable		 3ogpB-2oqrA:
18.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2p0w HISTONE
ACETYLTRANSFERASE
TYPE B CATALYTIC
SUBUNIT

(Homo sapiens) 		PF10394
(Hat1_N) 		5 GLY A 140
ALA A 164
ASP A 165
GLY A 170
LEU A 203
 ACM  A 803 (-3.7A)
None
ACM  A 803 ( 4.8A)
None
None
 1.03A 3ogpB-2p0wA:
undetectable		 3ogpB-2p0wA:
18.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qq1 MOLYBDENUM COFACTOR
BIOSYNTHESIS MOG

(Aquifex
aeolicus) 		PF00994
(MoCF_biosynth) 		5 GLY A  27
ILE A  13
GLY A   9
ILE A   8
LEU A 134
 None
 1.02A 3ogpB-2qq1A:
undetectable		 3ogpB-2qq1A:
25.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2r5m POLYCOMB PROTEIN SCM

(Drosophila
melanogaster) 		PF02820
(MBT) 		6 ALA A 225
ASP A 240
ILE A 224
GLY A 208
ILE A 207
LEU A 237
 None
 1.48A 3ogpB-2r5mA:
undetectable		 3ogpB-2r5mA:
16.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2r9h H(+)/CL(-) EXCHANGE
TRANSPORTER CLCA

(Escherichia
coli) 		PF00654
(Voltage_CLC) 		5 GLY A 221
ALA A  39
ILE A  35
GLY A 159
ILE A 158
 None
 1.04A 3ogpB-2r9hA:
undetectable		 3ogpB-2r9hA:
14.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1) 		PF00077
(RVP) 		6 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 AB1  A 501 (-2.4A)
AB1  A 501 (-3.9A)
AB1  A 501 (-3.5A)
AB1  A 501 ( 3.3A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
 0.34A 3ogpB-2rkfA:
15.2		 3ogpB-2rkfA:
27.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2rsp RSV PROTEASE

(Rous sarcoma
virus) 		PF00077
(RVP) 		5 ASP A  37
GLY A  39
ALA A  40
ASP A  41
ILE A  42
 None
 0.19A 3ogpB-2rspA:
12.2		 3ogpB-2rspA:
26.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2yyt OROTIDINE
5'-PHOSPHATE
DECARBOXYLASE

(Geobacillus
kaustophilus) 		PF00215
(OMPdecase) 		5 GLY A  82
ALA A  83
ASP A  84
ILE A  47
LEU A  78
 None
 0.87A 3ogpB-2yytA:
undetectable		 3ogpB-2yytA:
17.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3aqp PROBABLE SECDF
PROTEIN-EXPORT
MEMBRANE PROTEIN

(Thermus
thermophilus) 		PF02355
(SecD_SecF)
PF07549
(Sec_GG) 		5 GLY A 281
ILE A 683
GLY A 274
ILE A 275
LEU A 335
 None
 1.02A 3ogpB-3aqpA:
undetectable		 3ogpB-3aqpA:
9.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3aw8 PHOSPHORIBOSYLAMINOI
MIDAZOLE
CARBOXYLASE, ATPASE
SUBUNIT

(Thermus
thermophilus) 		PF02222
(ATP-grasp) 		5 GLY A  18
ALA A  17
ILE A 271
GLY A  11
ILE A   4
 None
 0.94A 3ogpB-3aw8A:
undetectable		 3ogpB-3aw8A:
13.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ce9 GLYCEROL
DEHYDROGENASE

(Clostridium
acetobutylicum) 		PF13685
(Fe-ADH_2) 		5 ALA A 102
ASP A 101
ILE A  72
GLY A  95
ILE A  94
 PEG  A 404 ( 4.7A)
None
None
None
None
 0.85A 3ogpB-3ce9A:
undetectable		 3ogpB-3ce9A:
17.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3cwc PUTATIVE GLYCERATE
KINASE 2

(Salmonella
enterica) 		PF02595
(Gly_kinase) 		5 GLY A 254
ALA A 255
ILE A 233
GLY A 262
LEU A 244
 None
 0.91A 3ogpB-3cwcA:
undetectable		 3ogpB-3cwcA:
14.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fbg PUTATIVE ARGINATE
LYASE

(Staphylococcus
haemolyticus) 		PF00107
(ADH_zinc_N)
PF08240
(ADH_N) 		5 GLY A 193
ALA A 194
ASP A 195
ILE A 177
ILE A 168
 None
 1.02A 3ogpB-3fbgA:
undetectable		 3ogpB-3fbgA:
17.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fd0 PUTATIVE
CYSTATHIONINE
BETA-LYASE INVOLVED
IN ALUMINUM
RESISTANCE

(Listeria
innocua) 		PF06838
(Met_gamma_lyase) 		5 GLY A 216
ALA A 217
ASP A 218
ILE A 219
MET A 161
 EDO  A 416 (-3.4A)
None
EDO  A 416 ( 4.8A)
None
None
 0.96A 3ogpB-3fd0A:
undetectable		 3ogpB-3fd0A:
16.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gmi UPF0348 PROTEIN
MJ0951

(Methanocaldococcus
jannaschii) 		PF05636
(HIGH_NTase1)
PF16581
(HIGH_NTase1_ass) 		5 GLY A 111
ALA A 112
ASP A 113
ILE A  80
GLY A  73
 None
 1.01A 3ogpB-3gmiA:
undetectable		 3ogpB-3gmiA:
16.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hrv TOXIN COREGULATED
PILIN

(Vibrio cholerae) 		PF05946
(TcpA) 		5 GLY A 160
ALA A 157
ASP A 156
ILE A 179
LEU A 174
 None
 1.03A 3ogpB-3hrvA:
undetectable		 3ogpB-3hrvA:
18.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hvy CYSTATHIONINE
BETA-LYASE FAMILY
PROTEIN, YNBB
B.SUBTILIS ORTHOLOG

(Clostridium
acetobutylicum) 		PF06838
(Met_gamma_lyase) 		5 GLY A 233
ALA A 234
ASP A 235
ILE A 236
ILE A 201
 None
 0.82A 3ogpB-3hvyA:
undetectable		 3ogpB-3hvyA:
13.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3i5g MYOSIN HEAVY CHAIN
ISOFORM A

(Doryteuthis
pealeii) 		PF00063
(Myosin_head)
PF00612
(IQ)
PF02736
(Myosin_N) 		5 GLY A 264
ALA A 265
ASP A 266
GLY A 460
ILE A 459
 None
 0.88A 3ogpB-3i5gA:
undetectable		 3ogpB-3i5gA:
9.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ip1 ALCOHOL
DEHYDROGENASE,
ZINC-CONTAINING

(Thermotoga
maritima) 		PF00107
(ADH_zinc_N)
PF08240
(ADH_N) 		5 GLY A 256
ALA A 257
ASP A 258
ILE A 230
LEU A 241
 None
 0.98A 3ogpB-3ip1A:
undetectable		 3ogpB-3ip1A:
15.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3irz URO-ADHERENCE FACTOR
A

(Staphylococcus
saprophyticus) 		PF17210
(SdrD_B) 		5 GLY A 805
ALA A 804
ASP A 803
ILE A 802
GLY A 743
 None
 0.99A 3ogpB-3irzA:
undetectable		 3ogpB-3irzA:
14.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3jzl PUTATIVE
CYSTATHIONINE
BETA-LYASE INVOLVED
IN ALUMINUM
RESISTANCE

(Listeria
monocytogenes) 		PF06838
(Met_gamma_lyase) 		5 GLY A 216
ALA A 217
ASP A 218
ILE A 219
MET A 161
 None
 0.98A 3ogpB-3jzlA:
undetectable		 3ogpB-3jzlA:
15.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ke6 PROTEIN
RV1364C/MT1410

(Mycobacterium
tuberculosis) 		PF07228
(SpoIIE)
PF13581
(HATPase_c_2) 		6 GLY A 175
ALA A 176
ASP A 177
ILE A 178
GLY A 320
LEU A 267
 None
 1.34A 3ogpB-3ke6A:
undetectable		 3ogpB-3ke6A:
15.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3liu PUTATIVE CELL
ADHESION PROTEIN

(Parabacteroides
distasonis) 		PF06321
(P_gingi_FimA) 		5 GLY A 201
ALA A 202
ASP A 203
ILE A 354
LEU A 219
 None
 1.03A 3ogpB-3liuA:
undetectable		 3ogpB-3liuA:
14.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lp6 PHOSPHORIBOSYLAMINOI
MIDAZOLE CARBOXYLASE
CATALYTIC SUBUNIT

(Mycobacterium
tuberculosis) 		PF00731
(AIRC) 		5 GLY A  71
ALA A  70
ASP A  19
GLY A 122
ILE A 121
 FMT  A 175 (-4.1A)
FMT  A 175 ( 4.3A)
FMT  A 175 (-3.5A)
None
None
 1.03A 3ogpB-3lp6A:
undetectable		 3ogpB-3lp6A:
22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1) 		PF00077
(RVP) 		5 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
 None
 0.80A 3ogpB-3mwsA:
16.1		 3ogpB-3mwsA:
28.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1) 		PF00077
(RVP) 		6 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 0.36A 3ogpB-3mwsA:
16.1		 3ogpB-3mwsA:
28.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3prl NADP-DEPENDENT
GLYCERALDEHYDE-3-PHO
SPHATE DEHYDROGENASE

(Bacillus
halodurans) 		PF00171
(Aldedh) 		6 ALA A 114
ASP A 115
ILE A 116
GLY A 108
ILE A 107
LEU A  84
 None
 1.22A 3ogpB-3prlA:
undetectable		 3ogpB-3prlA:
13.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3q58 N-ACETYLMANNOSAMINE-
6-PHOSPHATE
2-EPIMERASE

(Salmonella
enterica) 		PF04131
(NanE) 		5 GLY A  98
ALA A  99
ASP A 100
ILE A 101
LEU A  94
 PEG  A 239 ( 4.2A)
None
PEG  A 241 ( 3.4A)
None
None
 0.79A 3ogpB-3q58A:
undetectable		 3ogpB-3q58A:
17.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3qi7 PUTATIVE
TRANSCRIPTIONAL
REGULATOR

(Clostridioides
difficile) 		PF12683
(DUF3798) 		5 GLY A 179
ALA A 180
ASP A 250
ILE A 251
ILE A 394
 None
 1.01A 3ogpB-3qi7A:
undetectable		 3ogpB-3qi7A:
14.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3r2g INOSINE
5'-MONOPHOSPHATE
DEHYDROGENASE

(Legionella
pneumophila) 		PF00478
(IMPDH) 		5 GLY A 162
ALA A 163
ASP A 164
ILE A 165
LEU A 158
 None
 0.79A 3ogpB-3r2gA:
undetectable		 3ogpB-3r2gA:
17.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3rcm TATD FAMILY
HYDROLASE

(Pseudomonas
putida) 		PF01026
(TatD_DNase) 		5 ASP A   5
GLY A   7
ASP A 209
GLY A 178
LEU A 232
 None
None
CIT  A 289 (-3.3A)
None
None
 1.03A 3ogpB-3rcmA:
undetectable		 3ogpB-3rcmA:
17.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3slz GAG-PRO-POL
POLYPROTEIN

(Murine leukemia
virus) 		PF00077
(RVP) 		5 ASP A  32
GLY A  34
ALA A  35
GLY A  56
LEU A  92
 3TL  A 126 (-2.4A)
3TL  A 126 (-3.1A)
3TL  A 126 ( 4.0A)
3TL  A 126 (-3.4A)
3TL  A 126 (-4.6A)
 0.21A 3ogpB-3slzA:
12.0		 3ogpB-3slzA:
26.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1) 		PF00077
(RVP) 		6 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 017  A 201 (-2.6A)
017  A 201 (-3.4A)
017  A 201 (-3.5A)
017  A 201 (-3.5A)
017  A 201 (-4.0A)
017  A 201 (-3.3A)
 0.50A 3ogpB-3t3cA:
15.1		 3ogpB-3t3cA:
29.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3tqw METHIONINE-BINDING
PROTEIN

(Coxiella
burnetii) 		PF03180
(Lipoprotein_9) 		5 ASP A  47
GLY A  48
ILE A  72
GLY A   5
ILE A  33
 None
 0.86A 3ogpB-3tqwA:
undetectable		 3ogpB-3tqwA:
22.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1) 		PF00077
(RVP) 		6 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 017  A 201 (-2.6A)
017  A 201 (-3.6A)
017  A 201 (-3.4A)
017  A 201 (-3.3A)
017  A 201 (-3.0A)
017  A 201 (-3.3A)
 0.46A 3ogpB-3ttpA:
15.5		 3ogpB-3ttpA:
26.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1) 		PF00077
(RVP) 		6 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 017  A 202 ( 2.5A)
017  A 201 ( 3.5A)
017  A 201 (-3.4A)
017  A 201 (-3.2A)
017  A 202 (-2.9A)
017  A 201 ( 3.5A)
 0.32A 3ogpB-3u7sA:
15.4		 3ogpB-3u7sA:
28.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3wfl BETA-MANNANASE

(Talaromyces
trachyspermus) 		PF00150
(Cellulase) 		5 GLY A 302
ALA A 301
GLY A 295
ILE A 333
LEU A 263
 None
 0.90A 3ogpB-3wflA:
undetectable		 3ogpB-3wflA:
17.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4aec CYSTEINE SYNTHASE,
MITOCHONDRIAL

(Arabidopsis
thaliana) 		PF00291
(PALP) 		5 GLY A 221
ILE A 202
GLY A 187
ILE A 188
LEU A 224
 None
 0.97A 3ogpB-4aecA:
undetectable		 3ogpB-4aecA:
13.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4c1n CO
DEHYDROGENASE/ACETYL
-COA SYNTHASE,
IRON-SULFUR PROTEIN

(Carboxydothermus
hydrogenoformans) 		PF03599
(CdhD) 		5 GLY B  87
ALA B  88
ASP B  89
ILE B  90
LEU B  51
 None
 0.64A 3ogpB-4c1nB:
undetectable		 3ogpB-4c1nB:
17.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ckr EPITHELIAL DISCOIDIN
DOMAIN-CONTAINING
RECEPTOR 1

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 ASP A 795
GLY A 794
ASP A 850
ILE A 807
GLY A 846
 None
 1.05A 3ogpB-4ckrA:
undetectable		 3ogpB-4ckrA:
17.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4emw COENZYME A DISULFIDE
REDUCTASE

(Staphylococcus
aureus) 		PF02852
(Pyr_redox_dim)
PF07992
(Pyr_redox_2) 		5 GLY A 391
ALA A 392
ASP A 393
ILE A 325
ILE A 430
 None
 1.04A 3ogpB-4emwA:
undetectable		 3ogpB-4emwA:
13.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4eye PROBABLE
OXIDOREDUCTASE

(Mycobacteroides
abscessus) 		PF00107
(ADH_zinc_N)
PF08240
(ADH_N) 		5 GLY A 183
ALA A 184
ASP A 185
ILE A 167
ILE A 158
 None
 1.03A 3ogpB-4eyeA:
undetectable		 3ogpB-4eyeA:
15.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4f6t MOLYBDENUM STORAGE
PROTEIN SUBUNIT
ALPHA
MOLYBDENUM STORAGE
PROTEIN SUBUNIT BETA

(Azotobacter
vinelandii) 		PF00696
(AA_kinase) 		5 GLY B  97
ALA B  96
ILE B 164
GLY B  93
ILE A  35
 None
 0.71A 3ogpB-4f6tB:
undetectable		 3ogpB-4f6tB:
16.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4h0p ACETATE KINASE

(Cryptococcus
neoformans) 		PF00871
(Acetate_kinase) 		5 GLY A 381
ALA A 382
GLY A 355
ILE A 353
LEU A 377
 None
 0.94A 3ogpB-4h0pA:
undetectable		 3ogpB-4h0pA:
15.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ida RIPENING-INDUCED
PROTEIN

(Fragaria vesca) 		PF08240
(ADH_N)
PF13602
(ADH_zinc_N_2) 		5 GLY A 208
ALA A 209
ASP A 210
ILE A 179
LEU A 204
 None
 1.00A 3ogpB-4idaA:
undetectable		 3ogpB-4idaA:
17.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4iug BETA-GALACTOSIDASE A

(Aspergillus
oryzae) 		PF01301
(Glyco_hydro_35)
PF10435
(BetaGal_dom2)
PF13363
(BetaGal_dom3)
PF13364
(BetaGal_dom4_5) 		5 ASP A  98
GLY A 147
ALA A 100
GLY A 801
LEU A 101
 None
 1.05A 3ogpB-4iugA:
undetectable		 3ogpB-4iugA:
7.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4jos ADENOSYLHOMOCYSTEINE
NUCLEOSIDASE

(Francisella
philomiragia) 		PF01048
(PNP_UDP_1) 		6 GLY A   8
ALA A   9
ILE A  51
MET A 172
GLY A 174
ILE A 190
 None
None
None
ADE  A 301 (-4.1A)
None
None
 1.30A 3ogpB-4josA:
undetectable		 3ogpB-4josA:
19.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4lgl GLYCINE
DEHYDROGENASE
[DECARBOXYLATING]

(Synechocystis
sp. PCC 6803) 		PF02347
(GDC-P) 		5 GLY A 280
ALA A 281
ASP A 282
ILE A 283
LEU A 263
 None
 0.72A 3ogpB-4lglA:
undetectable		 3ogpB-4lglA:
8.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4lma CYSTEINE SYNTHASE

(Microcystis
aeruginosa) 		PF00291
(PALP) 		5 GLY A 113
ILE A  94
GLY A  79
ILE A  80
LEU A 116
 None
 0.99A 3ogpB-4lmaA:
undetectable		 3ogpB-4lmaA:
18.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4mi2 PUTATIVE ENOYL-COA
HYDRATASE/ISOMERASE

(Mycobacteroides
abscessus) 		PF00378
(ECH_1) 		5 GLY A 125
ALA A 126
ASP A 127
ILE A 128
ILE A  21
 None
 1.04A 3ogpB-4mi2A:
undetectable		 3ogpB-4mi2A:
18.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1) 		PF00077
(RVP) 		5 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
 RIT  A 500 (-2.4A)
RIT  A 500 (-3.9A)
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
RIT  A 500 (-4.8A)
 0.77A 3ogpB-4njvA:
15.2		 3ogpB-4njvA:
32.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1) 		PF00077
(RVP) 		6 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 RIT  A 500 (-2.4A)
RIT  A 500 (-3.9A)
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
RIT  A 500 (-3.4A)
RIT  A 500 (-4.3A)
 0.41A 3ogpB-4njvA:
15.2		 3ogpB-4njvA:
32.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4og1 ENOYL-COA
HYDRATASE/ISOMERASE

(Novosphingobium
aromaticivorans) 		PF00378
(ECH_1) 		5 GLY A 128
ALA A 129
ASP A 130
ILE A 111
LEU A  58
 None
 1.03A 3ogpB-4og1A:
undetectable		 3ogpB-4og1A:
16.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ov6 PROPROTEIN
CONVERTASE
SUBTILISIN/KEXIN
TYPE 9

(Homo sapiens) 		PF00082
(Peptidase_S8) 		5 GLY B 394
ALA B 393
ILE B 334
ILE B 368
LEU B 286
 None
 1.02A 3ogpB-4ov6B:
undetectable		 3ogpB-4ov6B:
17.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4p7y METHIONINE
GAMMA-LYASE

(Citrobacter
freundii) 		PF01053
(Cys_Met_Meta_PP) 		5 GLY A 200
ALA A 201
ASP A 202
ILE A 203
ILE A 174
 None
 0.77A 3ogpB-4p7yA:
undetectable		 3ogpB-4p7yA:
14.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4qiw DNA-DIRECTED RNA
POLYMERASE SUBUNIT K
DNA-DIRECTED RNA
POLYMERASE, SUBUNIT
E'

(Thermococcus
kodakarensis) 		PF00575
(S1)
PF01192
(RNA_pol_Rpb6)
PF03876
(SHS2_Rpb7-N) 		5 ASP E  63
GLY E  64
ALA E  65
ILE E  13
GLY K  23
 None
 1.00A 3ogpB-4qiwE:
undetectable		 3ogpB-4qiwE:
20.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4rgh PROTEIN DDI1 HOMOLOG
2

(Homo sapiens) 		PF09668
(Asp_protease) 		5 ASP A 220
GLY A 222
ALA A 223
GLY A 252
LEU A 289
 None
 1.04A 3ogpB-4rghA:
11.0		 3ogpB-4rghA:
22.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4u1r ATP-DEPENDENT
6-PHOSPHOFRUCTOKINAS
E, PLATELET TYPE

(Homo sapiens) 		PF00365
(PFK) 		5 GLY A 599
ALA A 600
ASP A 601
ILE A 566
LEU A 636
 PO4  A 804 (-3.9A)
None
None
None
None
 1.04A 3ogpB-4u1rA:
undetectable		 3ogpB-4u1rA:
9.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wfs TRNA-DIHYDROURIDINE(
20) SYNTHASE
[NAD(P)+]-LIKE

(Homo sapiens) 		PF01207
(Dus) 		5 GLY A  35
ALA A  36
ASP A  37
ILE A  38
LEU A  16
 None
 0.97A 3ogpB-4wfsA:
undetectable		 3ogpB-4wfsA:
15.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4y0w YEAZ

(Pseudomonas
aeruginosa) 		PF00814
(Peptidase_M22) 		5 ASP A   8
GLY A  63
ILE A  74
GLY A  67
ILE A 116
 NA  A 302 (-3.6A)
None
None
None
None
 1.05A 3ogpB-4y0wA:
undetectable		 3ogpB-4y0wA:
17.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ydf HTLV-1 PROTEASE

(Primate
T-lymphotropic
virus 1) 		PF00077
(RVP) 		5 ASP A  32
GLY A  34
ALA A  35
ASP A  36
GLY A  58
 4B1  A 201 (-2.9A)
4B1  A 201 ( 4.6A)
4B1  A 201 (-3.6A)
4B1  A 201 (-4.4A)
4B1  A 201 (-3.4A)
 0.34A 3ogpB-4ydfA:
12.3		 3ogpB-4ydfA:
26.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4yzo PUTATIVE ACYL-COA
ACYLTRANSFERASE

(Sulfurisphaera
tokodaii) 		PF00108
(Thiolase_N)
PF02803
(Thiolase_C) 		5 GLY A 102
ALA A 324
ILE A 322
GLY A  80
ILE A  83
 None
 1.02A 3ogpB-4yzoA:
undetectable		 3ogpB-4yzoA:
15.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ey5 LBCATS-A

(synthetic
construct) 		PF00290
(Trp_syntA) 		5 GLY A  44
ALA A  45
ASP A  46
ILE A  47
LEU A  40
 None
 0.82A 3ogpB-5ey5A:
undetectable		 3ogpB-5ey5A:
17.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5fi5 TETRAHYDROALSTONINE
SYNTHASE

(Catharanthus
roseus) 		PF00107
(ADH_zinc_N)
PF08240
(ADH_N) 		5 GLY A 192
ILE A 251
GLY A 184
ILE A 183
LEU A 273
 None
 0.95A 3ogpB-5fi5A:
undetectable		 3ogpB-5fi5A:
14.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5gne LEUCINE
AMINOPEPTIDASE

(Legionella
pneumophila) 		PF04389
(Peptidase_M28) 		5 ALA A 224
ASP A 225
ILE A 374
ILE A 136
LEU A 372
 None
 1.04A 3ogpB-5gneA:
undetectable		 3ogpB-5gneA:
14.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5h28 OXYSTEROL-BINDING
PROTEIN HOMOLOG 1

(Saccharomyces
cerevisiae) 		PF13637
(Ank_4) 		5 GLY A 220
ALA A 221
ASP A 222
GLY A 191
LEU A 216
 None
 1.03A 3ogpB-5h28A:
undetectable		 3ogpB-5h28A:
19.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5h53 SKELETAL MUSCLE
MYOSIN HEAVY CHAIN
MYHC-EO/IIL

(Oryctolagus
cuniculus) 		PF00063
(Myosin_head)
PF02736
(Myosin_N) 		5 ALA A 263
ASP A 264
ILE A 265
GLY A 460
ILE A 459
 None
 0.95A 3ogpB-5h53A:
undetectable		 3ogpB-5h53A:
9.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5jyg ACTIN-LIKE ATPASE

(Magnetospirillum
magneticum) 		PF06723
(MreB_Mbl) 		5 GLY A 288
ALA A 287
ASP A 161
ILE A 159
GLY A 322
 ADP  A 402 ( 4.2A)
None
MG  A 401 (-3.8A)
None
None
 1.04A 3ogpB-5jygA:
undetectable		 3ogpB-5jygA:
16.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5szs SPIKE GLYCOPROTEIN

(Human
coronavirus
NL63) 		PF01600
(Corona_S1)
PF01601
(Corona_S2) 		5 ASP A 836
ALA A 839
ILE A 934
MET A 937
GLY A 940
 None
 1.02A 3ogpB-5szsA:
undetectable		 3ogpB-5szsA:
6.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t2z PROTEASE

(Human
immunodeficiency
virus 1) 		PF00077
(RVP) 		6 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 0.40A 3ogpB-5t2zA:
15.3		 3ogpB-5t2zA:
31.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5t79 ALDO-KETO REDUCTASE,
OXIDOREDUCTASE

(Salmonella
enterica) 		PF00248
(Aldo_ket_red) 		5 GLY A  99
ALA A  98
GLY A 166
ILE A 167
LEU A 116
 None
 0.96A 3ogpB-5t79A:
undetectable		 3ogpB-5t79A:
16.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5tgf UNCHARACTERIZED
PROTEIN

(Bacteroides
dorei) 		PF00144
(Beta-lactamase) 		5 GLY A  69
ALA A  70
ASP A  73
GLY A 221
ILE A 217
 None
 0.85A 3ogpB-5tgfA:
undetectable		 3ogpB-5tgfA:
16.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vis DIHYDROPTEROATE
SYNTHASE

(soil metagenome) 		PF00809
(Pterin_bind) 		5 GLY A  40
ALA A  41
ASP A  42
ILE A  43
LEU A  36
 None
 0.82A 3ogpB-5visA:
undetectable		 3ogpB-5visA:
17.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vlh PROPROTEIN
CONVERTASE
SUBTILISIN/KEXIN
TYPE 9

(Homo sapiens) 		PF00082
(Peptidase_S8)
PF05922
(Inhibitor_I9) 		5 GLY A 394
ALA A 393
ILE A 334
ILE A 368
LEU A 286
 None
 1.01A 3ogpB-5vlhA:
undetectable		 3ogpB-5vlhA:
13.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5w1a MYOSIN HEAVY CHAIN,
MUSCLE

(Drosophila
melanogaster) 		no annotation 5 GLY A 259
ALA A 260
ASP A 261
GLY A 457
ILE A 456
 None
 1.05A 3ogpB-5w1aA:
undetectable		 3ogpB-5w1aA:
20.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xcb PROBABLE SURFACE
PROTEIN

(Clostridium
perfringens) 		no annotation 5 GLY A 132
ALA A  60
ASP A  59
ILE A  61
ILE A  92
 None
 0.98A 3ogpB-5xcbA:
undetectable		 3ogpB-5xcbA:
19.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xcc PROBABLE SURFACE
PROTEIN

(Clostridium
perfringens) 		no annotation 5 GLY A 132
ALA A  60
ASP A  59
ILE A  61
ILE A  92
 None
 0.96A 3ogpB-5xccA:
undetectable		 3ogpB-5xccA:
19.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6fiv RETROPEPSIN

(Feline
immunodeficiency
virus) 		PF00077
(RVP) 		8 ASP A  30
GLY A  32
ALA A  33
ASP A  34
ILE A  35
MET A  56
GLY A  58
LEU A 101
 3TL  A 201 (-3.5A)
3TL  A 201 (-3.4A)
3TL  A 201 (-4.0A)
3TL  A 201 (-3.9A)
3TL  A 201 ( 4.3A)
3TL  A 201 (-4.7A)
3TL  A 201 (-3.4A)
3TL  A 201 (-4.8A)
 0.46A 3ogpB-6fivA:
22.0		 3ogpB-6fivA:
95.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6gbc MOLYBDOPTERIN
BIOSYNTHESIS PROTEIN
CNX1

(Arabidopsis
thaliana) 		no annotation 5 GLY A 346
ALA A 345
ILE A 341
GLY A  45
ILE A 169
 None
 0.93A 3ogpB-6gbcA:
undetectable		 3ogpB-6gbcA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2) 		PF00077
(RVP) 		5 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
 0.72A 3ogpB-6upjA:
15.5		 3ogpB-6upjA:
29.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2) 		PF00077
(RVP) 		5 ASP A  25
GLY A  27
ASP A  29
GLY A  49
ILE A  50
 NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
 0.83A 3ogpB-6upjA:
15.5		 3ogpB-6upjA:
29.17